Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Microfluidics-Enabled Nanoparticle for Multiscale Synergetic Osteoarthritis Therapy.

Chao Xie1,2, Huiwen Lu3, Jingle Chen1

  • 1Department of Joint and Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P. R. China.

ACS Nano
|June 9, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Hypoxia-Inducible Factor 1-Alpha Accumulation Disrupts the Articular Niche to Promote Osteoarthritis Pathogenesis.

Aging cell·2026
Same author

Associations between fear of cancer recurrence and post-traumatic growth in patients with primary liver cancer: a latent profile analysis and mediation analysis.

Frontiers in psychiatry·2026
Same author

Targeting Dnmt3a/m5C/RelA Axis Attenuates Microglia Inflammatory Response and Improves Postoperative Recovery in Chronic Compressive Cervical Spinal Cord Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Modulating burn wound immunity and vasculature with a photo-crosslinkable glycyrrhizic acid-ginsenoside hydrogel.

Biomedical materials (Bristol, England)·2026
Same author

Study on Early Pregnancy Diagnosis of Sows Based on Body Fluid Metabolite Detection Combined with Machine Learning Models.

Veterinary sciences·2026
Same author

Ungeremine suppresses colon cancer cell proliferation through inhibition of the PI3K/AKT/mTOR signaling pathway.

Applied biochemistry and biotechnology·2026
This summary is machine-generated.

A novel nanoparticle, ZCMC, offers a promising multiscale therapy for osteoarthritis (OA). It enhances joint lubrication, reduces inflammation, and promotes cartilage repair by targeting key cellular pathways.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Rheumatology

Background:

  • Osteoarthritis (OA) involves complex biomechanical and biochemical imbalances leading to cartilage degradation.
  • Current OA treatments often fail to address the multifaceted nature of the disease.
  • Simultaneous intervention in biomechanics, chondrocyte metabolism, and homeostasis is crucial for effective OA therapy.

Purpose of the Study:

  • To develop and evaluate a microfluidics-enabled nanoparticle (ZCMC) for synergistic, multiscale osteoarthritis therapy.
  • To investigate ZCMC's potential in restoring cartilage function and inhibiting OA progression.

Main Methods:

  • ZCMC nanoparticles were synthesized by grafting magnesium-modified chondroitin sulfate onto a cannabidiol (CBD)-loaded zein core.
  • In vitro and in vivo studies assessed ZCMC's effects on cartilage friction, inflammation, chondrocyte aging, and joint damage.
Keywords:
Cartilage explantsChondrocyte metabolismLubrication dysfunctionNanoparticlesOsteoarthritis

More Related Videos

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Related Experiment Videos

Last Updated: Jun 10, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

  • Transcriptome analysis was employed to elucidate the molecular mechanisms of ZCMC action, focusing on SCN9A and Nav1.7 channels.
  • Preclinical evaluation using human OA cartilage explants validated ZCMC's therapeutic potential.

    • Main Results:

    • ZCMC significantly reduced OA cartilage friction to levels comparable to healthy cartilage.
    • Sustained release of CBD and magnesium ions provided anti-inflammatory, analgesic, and chondroprotective effects.
    • ZCMC inhibited chondrocyte aging, regulated autophagy, and preserved cartilage matrix.
    • In vivo studies showed improved gait function, reduced joint damage, and prevention of nerve demyelination.
    • ZCMC downregulated SCN9A expression, inhibiting Nav1.7 channels to promote cellular homeostasis and cartilage repair.
    • Human OA cartilage explants demonstrated inhibited degradation and restored chondrocyte mechanical properties.

    Conclusions:

    • ZCMC nanoparticles represent a promising therapeutic strategy for osteoarthritis by simultaneously addressing multiple pathological pathways.
    • The multiscale synergistic approach of ZCMC offers potential for significant clinical translation in OA treatment.
    • Targeting Nav1.7 channels via ZCMC facilitates chondrocyte homeostasis and cartilage recovery, inhibiting OA progression.